Home
Eilat Field School

Eilat Field School Market Share Analysis for November 2025

אנחנו שומרים על האוויר, הקרקע, המזון והמים של כולנו: חיות הבר, הצמחים ובני האדם. רוצים להצטרף למסע המופלא? בואו להיות חברים להגנת הטבע >>

Travel and Tourism

Domainteva.org.il

Year Founded1953

Employees201 - 500

Annual Revenue--

Eilat Field School

Eilat Field School (including company regionals)

teva.org.il

See more website traffic and engagement information

Total visits to Eilat Field School's top domains

Understand Eilat Field School market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

teva.org.il141.6K

See more with Sales Intelligence

Avg. visit duration in Eilat Field School's top domains

Analyze Eilat Field School engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

teva.org.il00:01:23

See more with Sales Intelligence

Avg. pageviews on Eilat Field School's top domains

See how Eilat Field School keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

teva.org.il3.10

See more with Sales Intelligence

Eilat Field School top competitors by domain

Top similar sites in November 2025, ranked by their affinity

parks.org.ilCompany NameParksEmployees1001 - 5000HQIsrael, JerusalemAnnual revenue--Total visits577.7KHome and Garden > Gardening

Top technologies used by Eilat Field School

These are the website technologies, by industry, used by Eilat Field School top domains

Payment & Currencies (26)

Cart Functionality

Advertising (12)

DoubleClick

Social (11)

Google+ Platform

Conversion & Analytics (6)

Google Analytics

More Technologies

9

See all

News & Signals from Eilat Field School

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTeva invested into assets: plant in the amount of $2.3B on Jan 1st '16.Israel-based Teva ( TEVA.N ), the world's largest generic drugmaker, bought the Rimsa plant in 2016 in a $2.3 billion deal, only to shut it down immediately, saying the operation was overrun by improprieties.